Oaktree Acquisition Corp. III Life Sciences OACC
- Market cap
- $263.3M
- Revenue, 12 months
- n/m
- not a meaningful number
Charts
Financials
| Income statement | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|
| −$48.1K | −$303.7K | −$444.8K | −$269.8K | −$225.6K+369% | −$255.5K−16% | −$456.5K+3% | −$262K−3% | |
| Net income | −$48.1K | $1.4M | $1.7M | $1.9M | $2M | $1.8M+30% | $1.4M−16% | $1.6M−14% |
| −$0.01 | $0.27 | $0.07 | $0.08 | $0.08 | $0.33+22% | $0.06−14% | $0.07−13% | |
| 4.4M | 5M | 5.4M | 5.4M | 5.4M+23% | 5.4M+7% | 5.4M+0% | 5.4M+0% |
EPS, diluted: Q4 FY24 and Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 8 periods, Q3 FY24 to Q2 FY26: not printed by the filing, worked out from its own lines.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Financial Services nearest Oaktree Acquisition Corp. III Life Sciences' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| OACCOaktree Acquisition Corp. III Life Sciences | $263.3M | n/m | 19.5× | n/m | n/m | n/m | |
| RMBIRichmond Mutual Bancorporation | $266.5M | 13.1× | 13.1× | n/m | +15% | 23.1% | |
| NKSHNational Bankshares | $257.9M | 12.7× | 16.5× | n/m | +21% | 33.6% | |
| VABKVirginia National Bankshares | $269.6M | 10.9× | 12.1× | n/m | +13% | 39.0% | |
| FXNCFirst National | $271.1M | 12.5× | 10.8× | n/m | +12% | 23.3% | |
| HWBKHawthorn Bancshares | $271.1M | 10.7× | 10.2× | n/m | +12% | 30.0% | |
| EFSIEagle Financial Services | $254M | 13.6× | 11.2× | n/m | +37% | 20.6% | |
| GBFHGBank Financial | $252.2M | 13.6× | 19.8× | n/m | +20% | 22.4% | |
| FNRNFirst Northern Community Bancorp | $275.6M | 12.5× | 7.9× | n/m | +5% | 30.0% | |
| SNFCASecurity National Financial | $250.5M | 6.4× | 5.8× | 0.7× | −1% | 11.1% | |
| WNEBWestern New England Bancorp | $278.2M | 16.5× | 16.4× | n/m | +17% | 19.0% | |
| Peer median | $268M | 12.6× | 11.6× | 0.7× | +14% | 23.2% |
More on Oaktree Acquisition Corp. III Life Sciences
Each number over time
Its groups
About
- Industry
- Shell Companies
- Sector
- Financial Services
Valuation data, not investment advice. Prices as of .